Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?
- DOI
- 10.1007/s00228-010-0966-3
- Published
- 2011-02-02
- Container
- European Journal of Clinical Pharmacology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00228-010-0966-3,
title = {Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?},
author = {Francesco Bellanti and Bertil Kågedal and Oscar Della Pasqua},
year = {2011},
journal = {European Journal of Clinical Pharmacology},
doi = {10.1007/s00228-010-0966-3},
url = {https://doi.org/10.1007/s00228-010-0966-3}
}RIS
TY - JOUR TI - Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma? AU - Francesco Bellanti AU - Bertil Kågedal AU - Oscar Della Pasqua PY - 2011 JO - European Journal of Clinical Pharmacology DO - 10.1007/s00228-010-0966-3 UR - https://doi.org/10.1007/s00228-010-0966-3 ER -
APA
Bellanti, F., Kågedal, B., & Pasqua, O. D. (2011). Do pharmacokinetic polymorphisms explain treatment failure in high-risk patients with neuroblastoma?. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-010-0966-3
Source records
- crossref · retrieved 2026-09-27T00:20:33.001Z